Human Genome Epidemiology Literature Finder
|
Records 1 - 20 (of 20 Records) |
| Query Trace: Disease and CSF3R[original query] |
|---|
| High-density polymorphisms analysis of 23 candidate genes for association with bone mineral density. Bone 2010 Nov 47 (5): 975-81. Giroux Sylvie, Elfassihi Latifa, Clément Valérie, Bussières Johanne, Bureau Alexandre, Cole David E C, Rousseau Franço |
| Prevalence and impact of colony stimulating factor 3 receptor (CSF3R) mutations among Egyptian acute myeloid leukemia patients. Leukemia research 2014 Jun 38 (6): 722-5. Aref Salah, El-Ghonemy Mohamed, Abouzeid Tarek, El-Sabbagh Amr, El-Baiomy Moham |
| Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2015 May 28 (5): 706-14. Ohgami Robert S, Ma Lisa, Merker Jason D, Gotlib Jason R, Schrijver Iris, Zehnder James L, Arber Daniel |
| Functional enrichment analysis of three Alzheimer's disease genome-wide association studies identities DAB1 as a novel candidate liability/protective gene. Biochemical and biophysical research communications 2015 Aug 463 (4): 490-5. Gao Hui, Tao Yu, He Qin, Song Fan, Saffen Dav |
| Chemo-genomic interrogation of CEBPA mutated AML reveals recurrent CSF3R mutations and subgroup sensitivity to JAK inhibitors. Blood 2016 Mar . Lavallée Vincent-Philippe, Krosl Jana, Lemieux Sébastien, Boucher Geneviève, Gendron Patrick, Pabst Caroline, Boivin Isabel, Marinier Anne, Guidos Cynthia J, Meloche Sylvain, Hébert Josée, Sauvageau G |
| Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignancies. Journal of cancer research and clinical oncology 2017 Sep . Winkelmann Nils, Schäfer Vivien, Rinke Jenny, Kaiser Alexander, Ernst Philipp, Scholl Sebastian, Hochhaus Andreas, Ernst Thom |
| CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia. Cancer 2018 Jun . Zhang Yang, Wang Fang, Chen Xue, Zhang Yu, Wang Mingyu, Liu Hong, Cao Panxiang, Ma Xiaoli, Wang Tong, Zhang Jianping, Zhang Xian, Lu Peihua, Liu Hongxi |
| Targeted resequencing reveals genetic risks in patients with sporadic idiopathic pulmonary fibrosis. Human mutation 2018 Jun . Deng Yanhan, Li Zongzhe, Liu Juan, Wang Zheng, Cao Yanyan, Mou Yong, Fu Bohua, Mo Biwen, Wei Jianghong, Cheng Zhenshun, Luo Liman, Li Jingping, Shu Ying, Wang Xiaomei, Luo Guangwei, Yang Shuo, Wang Yingnan, Zhu Jing, Yang Jingping, Wu Ming, Xu Xuyan, Ge Renying, Chen Xueqin, Peng Qingzhen, Wei Guang, Li Yaqing, Yang Hua, Fang Shirong, Zhang Xiaoju, Xiong Weini |
| Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 12 38 (10): 1006-1018. Dao Kim-Hien T, Gotlib Jason, Deininger Michael M N, Oh Stephen T, Cortes Jorge E, Collins Robert H, Winton Elliot F, Parker Dana R, Lee Hyunjung, Reister Anna, Schultz , Savage Samantha, Stevens , Brockett Chase, Subbiah Nan, Press Richard D, Raess Philipp W, Cascio Michael, Dunlap Jennifer, Chen Yiyi, Degnin Catherine, Maxson Julia E, Tognon Cristina E, Macey Tara, Druker Brian J, Tyner Jeffrey |
| Gene coexpression network analysis revealed biomarkers correlated with blast cells and survival in acute myeloid leukemia. Molecular and clinical oncology 2020 4 12 (5): 475-484. Pan Yuming, Zhang Qiaoxia, Deng Xiaopeng, An Na, Du Xin, Liu Jiaj |
| Mutation topography and risk stratification for de novo acute myeloid leukaemia with normal cytogenetics and no nucleophosmin 1 (NPM1) mutation or Fms-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD). British journal of haematology 2020 Feb . Zhou Ya-Lan, Wu Li-Xin, Peter Gale Robert, Wang Zi-Long, Li Jin-Lan, Jiang Hao, Jiang Qian, Jiang Bin, Cao Shan-Bo, Lou Feng, Sun Ying, Wang Cheng-Cheng, Liu Yan-Rong, Wang Yu, Chang Ying-Jun, Xu Lan-Ping, Zhang Xiao-Hui, Liu Kai-Yan, Ruan Guo-Rui, Huang Xiao-J |
| CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia. Annals of hematology 2021 Apr . Qian Yi, Chen Yan, Li Xiaomi |
| Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse. Transplantation and cellular therapy 2021 4 27 (8): 662.e1-662.e9. Newell Laura F, Williams Todd, Liu James, Yu Yun, Chen Yiyi, Booth Georgeann C, Knight Rebekah J, Goslee Kelli R, Cook Rachel J, Leonard Jessica, Meyers Gabrielle, Traer Elie, Press Richard D, Fan Guang, Wang Ying, Raess Philipp W, Maziarz Richard T, Dunlap Jennif |
| Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia. Current oncology (Toronto, Ont.) 2022 2 29 (2): 805-815. Adam Franziska C, Szybinski Jakub, Halter Jörg P, Cantoni Nathan, Wenzel Friedel, Leonards Katharina, Brkic Sime, Passweg Jakob R, Touw Ivo, Maxson Julia E, Meyer Sara |
| Differential Implications of CSF3R Mutations in t(8;21) and CEBPA Double Mutated Acute Myeloid Leukemia. Clinical lymphoma, myeloma & leukemia 2022 1 22 (6): 393-404. Wang Biao, Wen Lijun, Wang Zheng, Chen Suning, Qiu Huiyi |
| [Impact of CSF3R Mutation on Treatment Response and Survival of Patients with Acute Myeloid Leukemia]. Zhongguo shi yan xue ye xue za zhi 2023 6 31 (3): 628-632. Ruo-Qi Li, Xiao-Ling Wen, Xia-Lin Zhang, Chun-Xia Dong, Mei-Fang Wang, Xia-Xia Liu, Yan-Jun Huang, Yan-Hong Tan, Jian-Mei Chang, Rui-Juan Zha |
| Atypical CML: diagnosis and treatment. Hematology. American Society of Hematology. Education Program 2023 12 2023 (1): 476-482. Massimo Brecc |
| Comprehensive genomic profiling reveals molecular subsets of ASXL1-mutated myeloid neoplasms. Leukemia & lymphoma 2023 11 1-10. Steven M Johnson, James Haberberger, Jonathan Galeotti, Lori Ramkissoon, Catherine C Coombs, Daniel R Richardson, Matthew C Foster, Daniel Duncan, Nathan D Montgomery, Naomi L Ferguson, Joshua F Zeidn |
| [Restratifying the prognosis of acute myeloid leukemia patients with CEBPA double mutations based on CSF3R mutations and measurable residual disease]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 1 43 (12): 1021-1027. Su L, Tan Y H, Lin H, Han W, Yang Y P, Liu X L, Sun J N, Liu Q J, Gao S |
| Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry. Cancers 2023 1 15 (2): . Sargas Claudia, Ayala Rosa, Larráyoz María José, Chillón María Carmen, Carrillo-Cruz Estrella, Bilbao-Sieyro Cristina, Prados de la Torre Esther, Martínez-Cuadrón David, Rodríguez-Veiga Rebeca, Boluda Blanca, Gil Cristina, Bernal Teresa, Bergua Juan Miguel, Algarra Lorenzo, Tormo Mar, Martínez-Sánchez Pilar, Soria Elena, Serrano Josefina, Alonso-Domínguez Juan Manuel, García-Boyero Raimundo, Amigo María Luz, Herrera-Puente Pilar, Sayas María José, Lavilla-Rubira Esperanza, Martínez-López Joaquín, Calasanz María José, García-Sanz Ramón, Pérez-Simón José Antonio, Gómez-Casares María Teresa, Sánchez-García Joaquín, Barragán Eva, Montesinos Pau, On Behalf Of Pethema Grou |
- Page last reviewed:Feb 1, 2024
- Content source: